Diagnos Laboratorium Utama Tbk. vs Satyamitra Kemas Lestari Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 1.7K 24h volume), while Satyamitra Kemas Lestari Tbk. trades at Rp147 (market cap 502.46B, 21K 24h volume). The key difference: Satyamitra Kemas Lestari Tbk. is the larger of the two by market cap, and Satyamitra Kemas Lestari Tbk. is more actively traded (21K versus 1.7K). Which is the better fit depends on your goals.
| DGNS | SMKL | |
|---|---|---|
Market Cap | 319B | 502.46B |
Volume | 1.7K | 21K |
Lot | 17 | 210 |
Turnover | 392K | 3.15M |
Average Price | 230.59 | 149.98 |
Value | 392K | 3.15M |
Indicative Equilibrium Price | 232 | 150 |
Indicative Equilibrium Volume | 200 | 18 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Satyamitra Kemas Lestari Tbk (The Company) was established based on Deed of Establishment No. 12 dated July 26, 2001 which was made in the presence of Juniaty Tedjaputra, S.H., a notary in Tangerang.
Read more on SMKL →